Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership2,438 shares
Latest Disclosed Value $ 35,253
Us Bancorp \de\ reports 8.31% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 2,438 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $35,253 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 2,251 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 8.31% during the quarter. The current value of the position is $35,327 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 2,438 187 8.31 35 9.38 0.0000
2026-01-30 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,251 0 0.00 32 88.24 0.0000
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,251 1,148 104.08 18 183.33 0.0000
2025-07-24 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,103 -249 -18.42 6 -45.45 0.0000
2025-05-08 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,352 -3,532 -72.32 11 -76.09 0.0000
2025-02-05 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 4,884 -7,132 -59.35 46 -64.06 0.0001
2024-10-28 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 12,016 -12,846 -51.67 128 -47.97 0.0002
2024-08-07 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 24,862 984 4.12 247 -12.46 0.0003
2024-05-08 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 23,878 -3,316 -12.19 281 -27.01 0.0004
2024-02-09 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 27,194 3,591 15.21 386 34.15 0.0006
2023-11-03 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 23,603 -706 -2.90 287 -5.90 0.0005
2023-08-10 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 24,309 -8,564 -26.05 305 -16.21 0.0005
2023-05-09 2023-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 32,873 1,812 5.83 365 -3.96 0.0006
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 31,061 -16,498 -34.69 379 -23.90 0.0007
2022-10-27 2022-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 47,559 -1,733 -3.52 498 -5.86 0.0010
2022-08-01 2022-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 49,292 34,243 227.54 529 269.93 0.0010
2022-05-11 2022-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 15,049 14,960 16,808.99 143 14,200.00 0.0002
2022-02-11 2021-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 89 -10,818 -99.18 1 -99.04 0.0000
2021-11-10 2021-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 10,907 -2,275 -17.26 104 -18.11 0.0002
2021-08-05 2021-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 13,182 1,955 17.41 127 14.41 0.0002
2021-04-28 2021-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 11,227 10,907 3,408.44 111 1,485.71 0.0002
2021-02-04 2020-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 320 111 53.11 7 133.33 0.0000
2020-11-10 2020-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 209 0 0.00 3 0.00 0.0000
2020-08-07 2020-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 209 -219 -51.17 3 -25.00 0.0000
2020-05-13 2020-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 428 -175 -29.02 4 -33.33 0.0000
2020-02-04 2019-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 603 603 6 0.0000
2019-11-08 2019-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 0 -4,896 -100.00 0 -100.00
2019-08-13 2019-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,896 1,651 50.88 61 38.64 0.0002
2019-05-08 2019-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 3,245 2,548 365.57 44 528.57 0.0001
2019-02-13 2018-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 697 697 7 0.0000
2018-08-08 2018-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 0 -814 -100.00 0 -100.00
2018-05-08 2018-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 814 -3 -0.37 12 0.00 0.0000
2018-02-02 2017-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 817 4 0.49 12 0.00 0.0000
2017-11-13 2017-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 813 813 12 0.0000
2017-05-03 2017-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 0 -73 -100.00 0 0.0000
2017-02-08 2016-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 73 -4,732 -98.48 0 -100.00
2016-11-04 2016-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,805 0 0.00 36 38.46 0.0001
2016-08-10 2016-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,805 0 0.00 26 -36.59 0.0001
2016-05-13 2016-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,805 0 0.00 41 -12.77 0.0002
2016-02-10 2015-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,805 0 0.00 47 -29.85 0.0002
2015-11-16 2015-09-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 4,805 -6,240 -56.50 67 -57.05 0.0003
2015-08-10 2015-06-30 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 11,045 -410 -3.58 156 24.80 0.0006
2015-05-08 2015-03-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 11,455 -1,390 -10.82 125 16.82 0.0005
2015-02-13 2014-12-31 13F AMICUS THERAPEUTICS COMMON STOCK 03152W109 12,845 12,845 107 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.